Decision-tree model for health economic comparison of two long-acting somatostatin receptor ligand devices in France, Germany, and the UK
Rémi Marty1, Stéphane Roze1, Hannah Kurth21HEVA, Lyon, 2IPSEN, Boulogne-Billancourt, FranceBackground: Long-acting somatostatin receptor ligands (SRL) with product-specific formulation and means of administration are injected periodically in patients with acromegaly and...
Guardado en:
Autores principales: | Marty R, Roze S, Kurth H |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bf41481cd3594a0682ad4b04ce87116f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evaluation of long-acting somatostatin analog injection devices by nurses: a quantitative study
por: Adelman DT, et al.
Publicado: (2012) -
Evaluation of the cost per patient per injection of botulinum toxin A in upper limb spasticity: comparison of two preparations in 19 countries
por: Valentine W, et al.
Publicado: (2012) -
Medical device vigilance systems: India, US, UK, and Australia
por: Pooja Gupta, et al.
Publicado: (2010) -
Atherectomy devices: technology update
por: Akkus NI, et al.
Publicado: (2014) -
Liposuction devices: technology update
por: Shridharani SM, et al.
Publicado: (2014)